Vertex beat third-quarter expectations late Monday, but an analyst says Vertex stock needs more "to drive another leg of stock upside." ...

Companies announce stock splits all the time, and so far this year a number of high profile companies have divvied up their ...

Vertex Pharmaceuticals continues to excel with strong Q3 results and promising clinical progress, but its valuation may ...

Vertex, Inc. VERX reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance on ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.00% to $475.08 Wednesday, on what proved to be an all-around rough trading ...

Analysts project a 22.33% upside for Vertex stock, despite current bearish momentum. Vertex Pharmaceuticals Inc VRTX will be reporting its third-quarter earnings on Monday. Wall Street expects $4. ...

On that note, let's dive in and investigate how the bull thesis for buying Vertex stock just got even stronger. Vertex's push to diversify its portfolio of medicines away from its traditional ...

So which stock survived my selection criteria gauntlet to stand above all the rest? Vertex Pharmaceuticals (NASDAQ: VRTX). The big biotech leader's share price of around $475 remains below the $ ...

Corporate tax compliance software Vertex stock scores a breakout amid an array of acquisitions, as earnings growth begins to accelerate. As the U.S. stock market stabilizes following a recent ...

From blue chip dividend stocks to industry-leading growth stocks, there are plenty of bargains in today's market if you know ...

Royalty Pharma's Q3 results show growth driven by strong portfolio performance and acquisitions. See why we recommend a buy ...